Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
leading cause of cancer deaths in this group. Figures vary but some studies put a figure of about 50-60 % of patients will have bone metastases in late stage cancer. The tumours weaken the bone and lead to
-
no edital disponível para download em https://www.ua.pt/file/88989 . Por favor, leia atentamente todo o edital, incluindo o ponto 13, para formalizar corretamente a sua candidatura, sob pena de exclusão. Em
-
Posting Details Posting Details Job Title Bone Marrow Lead Tech/UKHC Requisition Number RE53052 Working Title BM/MLT Lead Tech - Core Lab Department Name H3200:Laboratory Services Work Location
-
Psicologia (DEP) da Universidade de Aveiro (UA). O concurso encontra-se aberto nas condições explicitadas no edital disponível para download em https://www.ua.pt/file/88899 . Por favor, leia atentamente todo o
-
estimate of the range of possible compensation at the time of posting. Position Summary Reporting to the Director of the Metabolic Bone Diseases Program and the Endocrinology Practice Manager, the Clinical
-
group (www.bourginelab.com ) led by Paul Bourgine. The group specializes in the production of ossicles/bone tissue that recapitulate the structure and function of skeletal bone and bone marrow. In the
-
the application studies including, for example, reduced-order modelling of muscle forces and bone remodelling process, and surrogate modelling for FE simulation of bone mechanics. This project aims to tackle
-
Regulations, in force (https://www.fct.pt/apoios/bolsas/docs/RegulamentoBolsasFCT2019.pdf ); Regulation No. 522/2020, published in the Official Gazette, 2nd series, No. 113, of June 12 – Research Grant
-
State/Province Trás-os-Montes e Alto Douro City Vila Real Website http://www.utad.pt Street Quinta de Prados Postal Code 5000-801 E-Mail bolsasInvestigacao@utad.pt STATUS: EXPIRED X (formerly Twitter
-
Scientist position is available for a highly motivated candidate to work on a new DOE-funded project investigating the response to low doses of radiation in bone marrow stem cells, the target cell type